At present, in pharmacology one of the most serious problems is counterfeit drugs. The
Health Research Funding organization reported that in developing countries, nearly 10 …

Without a proper mechanism to track and authenticate drugs, both stakeholder and
consumer experience dilemmas. The dilemmas arise between stakeholders and consumers …

Modern healthcare systems are characterized as being highly complex and costly. However,
this can be reduced through improved health record management, utilization of insurance …

The production and distribution of counterfeit drugs is an urgent and increasingly critical
worldwide issue, especially in developing countries. The market value of pharmaceutical …

The purpose of this study is to overcome coordination flaws and enhance end-to-end
security in the drug distribution market (DDM). One of the major issues in drug market …

Recent advancements in information and communication technology is enabling a
significant revolution in e-Health research and industry. In the case of personal medical data …

The main issues with drug safety in the counterfeit medicine supply chain, are to do with how
the drugs are initially manufactured. The traceability of right and active pharmaceutical …

From the last decade, pharmaceutical companies are facing difficulties in tracking their
products during the supply chain process, allowing the counterfeiters to add their fake …

Blockchain is evolving to be a secure and reliable platform for secure data sharing in
application areas such as the financial sector, supply chain management, food industry …

Counterfeit drugs are one of the most severe threats to the pharmaceutical industry. World
Health Organization (WHO) highlights that nearly 1035% of the drugs, ie, one out of ten …